Desmopressin Acetate

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5903 publications

Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration.

Reduction of hemorrhagic complications after non-focal renal biopsy with pre-procedure desmopressin administration.

Journal: Diagnostic and interventional radiology (Ankara, Turkey)

Published: March 23, 2026

Pituitary Apoplexy With Marked Hyperprolactinemia in a 19-Year-Old Woman: A Case Report of Diagnostic Challenges and Surgical Management.

Pituitary Apoplexy With Marked Hyperprolactinemia in a 19-Year-Old Woman: A Case Report of Diagnostic Challenges and Surgical Management.

Journal: Cureus

Published: March 05, 2026

Multi-center comparison of corticotropin releasing hormone vs. desmopressin stimulation responses in inferior petrosal sinus sampling for Cushing's disease.

Multi-center comparison of corticotropin releasing hormone vs. desmopressin stimulation responses in inferior petrosal sinus sampling for Cushing's disease.

Journal: Clinical neurology and neurosurgery

Published: March 01, 2026

Severe Hypernatremia Due to Postoperative Diabetic Ketoacidosis and Transient Central Diabetes Insipidus: A Case Report.

Severe Hypernatremia Due to Postoperative Diabetic Ketoacidosis and Transient Central Diabetes Insipidus: A Case Report.

Journal: Cureus

Published: February 27, 2026

Intravenous Tranexamic Acid Combined with Intramyometrial Desmopressin During Laparoscopic Myomectomy: A Randomized Double-Blind Placebo-Controlled Trial.

Intravenous Tranexamic Acid Combined with Intramyometrial Desmopressin During Laparoscopic Myomectomy: A Randomized Double-Blind Placebo-Controlled Trial.

Journal: Journal of minimally invasive gynecology

Published: February 26, 2026

GFP Reporter System Reveals Cell-to-Cell Variability in Aquaporin-2 Expression.

GFP Reporter System Reveals Cell-to-Cell Variability in Aquaporin-2 Expression.

Journal: American journal of physiology. Cell physiology

Published: February 23, 2026

Real-World Safety and Effectiveness of an Initial 0.1 mg Dose of Desmopressin in Older Men with Nocturnal Polyuria.

Real-World Safety and Effectiveness of an Initial 0.1 mg Dose of Desmopressin in Older Men with Nocturnal Polyuria.

Journal: The Journal of urology

Published: February 20, 2026

Desmopressin for antiplatelet-associated traumatic intracranial hemorrhage: A systematic review.

Desmopressin for antiplatelet-associated traumatic intracranial hemorrhage: A systematic review.

Journal: Clinical neurology and neurosurgery

Published: February 07, 2026

Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey.

Use, efficacy, and safety of desmopressin for congenital nephrogenic diabetes insipidus in children: a nationwide survey.

Journal: Endocrine journal

Published: January 28, 2026

Past, Present, and Future of von Willebrand Disease.

Past, Present, and Future of von Willebrand Disease.

Journal: Advances in therapy

Published: January 16, 2026

Endogenous vasopressin and vasopressin receptor 2 in bladder as anti-diuretic / anti-spasmodic targets for the treatment of multifactorial nocturia.

Endogenous vasopressin and vasopressin receptor 2 in bladder as anti-diuretic / anti-spasmodic targets for the treatment of multifactorial nocturia.

Journal: Continence (Amsterdam, Netherlands)

Published: January 08, 2026

Younger, Lighter, Drier: The Impact of Age and Body Mass Index on Treatment Success in Pediatric Monosymptomatic Nocturnal Enuresis.

Younger, Lighter, Drier: The Impact of Age and Body Mass Index on Treatment Success in Pediatric Monosymptomatic Nocturnal Enuresis.

Journal: Children (Basel, Switzerland)

Published: January 07, 2026

Showing 1-12 of 5,903

Last Updated: 04/28/2026